Skip to main content
Clinical Trials/CTRI/2021/10/037017
CTRI/2021/10/037017
Not yet recruiting
未知

EUS â?? guided balloon-occluded gastrojejunostomy bypass (EPASS) versus uncovered duodenal stent for unresectable malignant gastric outlet obstruction.

SL Raheja Hospital0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: C00-D49- Neoplasms
Sponsor
SL Raheja Hospital
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
SL Raheja Hospital

Eligibility Criteria

Inclusion Criteria

  • All patients with unresectable malignant gastric outlet obstruction will be included in the study.
  • Valid consent

Exclusion Criteria

  • Coagulopathy
  • Significant ascites
  • no valid consent
  • Benign tumours
  • Neoadjuvant chemotherapy for current malignancy
  • Patients for whom endoscopic techniques are contraindicated
  • Participation in another investigational trial within 180 days

Outcomes

Primary Outcomes

Not specified

Similar Trials